PRA Health Sciences, Inc. (PRAH) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 177 transactions totaling $6.0B, demonstrating a bearish sentiment with -$6.0B in net insider flow. The most recent transaction on Jul 1, 2021 involved a transaction of 14,729 shares valued at $0.
No significant insider buying has been recorded for PRAH in the recent period.
No significant insider selling has been recorded for PRAH in the recent period.
Based on recent SEC filings, insider sentiment for PRAH is bearish with an Insider Alignment Score of 0/100 and a net flow of -$6.0B. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at PRA Health Sciences, Inc. (PRAH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading PRAH stock, having executed 177 transactions in the past 90 days. The most active insider is Pra Investors Gp Llc Kkr (Executive), who has made 4 transactions totaling $1.7B.
Get notified when executives and directors at PRAH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 1, 2021 | T. Barber Jeffrey | Executive | Disposition | 14,729 | $N/A | $0 | |
| Jul 1, 2021 | George Dickinson Alexander | Executive | Disposition | 5,407 | $N/A | $0 | |
| Jul 1, 2021 | Grais Linda | Executive | Disposition | 9,683 | $N/A | $0 | |
| Jul 1, 2021 | C. Momtazee James | Executive | Disposition | 3,521 | $N/A | $0 | |
| Jul 1, 2021 | D. Stettin Glen | Executive | Disposition | 1,049 | $N/A | $0 | |
| Jul 1, 2021 | P. Young Matthew | Executive | Disposition | 7,127 | $N/A | $0 | |
| Jul 1, 2021 | J. Bonello Michael | Executive | Disposition | 4,480 | $N/A | $0 | |
| Jul 1, 2021 | Shannon Colin | Executive | Disposition | 46,500 | $N/A | $0 | |
| Jul 1, 2021 | L. Gaenzle Christopher | Executive | Disposition | 34,500 | $N/A | $0 | |
| Jun 17, 2021 | Shannon Colin | Executive | Sale | 161,352 | $168.13 | $27.1M | Large |
| Jun 17, 2021 | Shannon Colin | Executive | Sale | 220,195 | $169.00 | $37.2M | Large |
| Jun 17, 2021 | Shannon Colin | Executive | Sale | 59,774 | $169.63 | $10.1M | Large |
| Jun 17, 2021 | Shannon Colin | Executive | Sale | 920 | $166.89 | $153.5K | |
| Jun 17, 2021 | Shannon Colin | Executive | Option Exercise | 31,780 | $103.30 | $3.3M | Large |
| Jun 17, 2021 | Shannon Colin | Executive | Option Exercise | 45,000 | $102.44 | $4.6M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 76 | $6.0B | 99.2% |
Exercise(M) | 44 | $45.7M | 0.8% |
Payment(F) | 6 | $1.7M | 0.0% |
Disposition(D) | 9 | $0 | 0.0% |
Award(A) | 37 | $0 | 0.0% |
Other(J) | 3 | $0 | 0.0% |
Gift(G) | 2 | $0 | 0.0% |
Insider selling pressure at PRA Health Sciences, Inc. has increased, with 21 insiders executing 177 transactions across all time. Total sales of $6.0B significantly outpace purchases of $0, resulting in a net outflow of $6.0B. This selling activity appears largely discretionary, which may warrant closer attention from investors.